Literature DB >> 23257828

Autocrine functions of VEGF in breast tumor cells: adhesion, survival, migration and invasion.

Martine Perrot-Applanat1, Melanie Di Benedetto.   

Abstract

Vascular endothelial growth factor A (VEGF-A) is well known for its key roles in blood vessel growth. Although most studies on VEGF and VEGF receptors have been focused on their functions in angiogenesis and in endothelial cells, the role of VEGF in cancer biology appears as an emerging area of importance. In this context, the presence of VEGF receptors in tumor cells strongly suggests that VEGF-A also promotes a wide range of functions, both in vitro and in vivo, all autocrine functions on tumor cells, including adhesion, survival, migration and invasion. Ultimately, refining our knowledge of VEGF signaling pathways in tumor cells should help us to understand why the current used treatments targeting the VEGF pathway in cancer are not universally effective in inhibiting metastasis tumors, and it should also provide new avenues for future therapies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23257828      PMCID: PMC3547902          DOI: 10.4161/cam.23332

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  74 in total

1.  The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules.

Authors:  H Gitay-Goren; S Soker; I Vlodavsky; G Neufeld
Journal:  J Biol Chem       Date:  1992-03-25       Impact factor: 5.157

2.  A dominant negative receptor for specific secreted semaphorins is generated by deleting an extracellular domain from neuropilin-1.

Authors:  M J Renzi; L Feiner; A M Koppel; J A Raper
Journal:  J Neurosci       Date:  1999-09-15       Impact factor: 6.167

3.  Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF(165) and VEGF(121).

Authors:  G B Whitaker; B J Limberg; J S Rosenbaum
Journal:  J Biol Chem       Date:  2001-05-01       Impact factor: 5.157

4.  A dynamic shift of VEGF isoforms with a transient and selective progesterone-induced expression of VEGF189 regulates angiogenesis and vascular permeability in human uterus.

Authors:  Magali Ancelin; Hélène Buteau-Lozano; Geri Meduri; Mary Osborne-Pellegrin; Sylvie Sordello; Jean Plouët; Martine Perrot-Applanat
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

5.  Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.

Authors:  S Soker; S Takashima; H Q Miao; G Neufeld; M Klagsbrun
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

6.  Semaphorin-neuropilin interactions underlying sympathetic axon responses to class III semaphorins.

Authors:  H Chen; Z He; A Bagri; M Tessier-Lavigne
Journal:  Neuron       Date:  1998-12       Impact factor: 17.173

7.  Neuropilin-1-VEGFR-2 complexing requires the PDZ-binding domain of neuropilin-1.

Authors:  Claudia Prahst; Mélanie Héroult; Anthony A Lanahan; Noa Uziel; Ofra Kessler; Niva Shraga-Heled; Michael Simons; Gera Neufeld; Hellmut G Augustin
Journal:  J Biol Chem       Date:  2008-07-15       Impact factor: 5.157

8.  Site-directed mutagenesis in the B-neuropilin-2 domain selectively enhances its affinity to VEGF165, but not to semaphorin 3F.

Authors:  Elena Geretti; Akio Shimizu; Peter Kurschat; Michael Klagsbrun
Journal:  J Biol Chem       Date:  2007-06-26       Impact factor: 5.157

9.  Neuropilin-1 extracellular domains mediate semaphorin D/III-induced growth cone collapse.

Authors:  F Nakamura; M Tanaka; T Takahashi; R G Kalb; S M Strittmatter
Journal:  Neuron       Date:  1998-11       Impact factor: 17.173

10.  Extract of Pleurotus pulmonarius suppresses liver cancer development and progression through inhibition of VEGF-induced PI3K/AKT signaling pathway.

Authors:  Wenwen Xu; Jim Jun-hui Huang; Peter Chi Keung Cheung
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

View more
  51 in total

1.  VEGF isoforms.

Authors:  Martine Perrot-Applanat
Journal:  Cell Adh Migr       Date:  2012-11-01       Impact factor: 3.405

2.  PTEN inhibits macrophage polarization from M1 to M2 through CCL2 and VEGF-A reduction and NHERF-1 synergism.

Authors:  Ning Li; Junfang Qin; Lan Lan; Hongyao Zhang; Fang Liu; Zhaozhen Wu; Hong Ni; Yue Wang
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

3.  Molecular expression of vascular endothelial growth factor, prokineticin receptor-1 and other biomarkers in infiltrating canalicular carcinoma of the breast.

Authors:  Angélica Morales; Sumiko Morimoto; Felipe Vilchis; Natsuko Taniyama; Claudia J Bautista; Carlos Robles; Enrique Bargalló
Journal:  Oncol Lett       Date:  2016-08-05       Impact factor: 2.967

4.  Anticancer effect of rapamycin on MCF-7 via downregulation of VEGF expression.

Authors:  Takaaki Fujii; Reina Yajima; Hironori Tatsuki; Katuya Oosone; Hiroyuki Kuwano
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-10-01       Impact factor: 2.416

5.  Unique serum immune phenotypes stratify Oklahoma Native American rheumatic disease patients.

Authors:  Samantha Slight-Webb; Carla J Guthridge; Joseph Kheir; Hua Chen; Ly Tran; Tim Gross; Virginia Roberts; Sohail Khan; Michael Peercy; Bobby Saunkeah; Joel M Guthridge; Judith A James
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-10-01       Impact factor: 4.794

Review 6.  Control of cellular motility by neuropilin-mediated physical interactions.

Authors:  Xiaobo Li; Matthew W Parker; Craig W Vander Kooi
Journal:  Biomol Concepts       Date:  2014-05

Review 7.  VEGF targets the tumour cell.

Authors:  Hira Lal Goel; Arthur M Mercurio
Journal:  Nat Rev Cancer       Date:  2013-12       Impact factor: 60.716

8.  Coral-derived compound WA-25 inhibits angiogenesis by attenuating the VEGF/VEGFR2 signaling pathway.

Authors:  Shih-Wei Lin; Shih-Chung Huang; Hsiao-Mei Kuo; Chiu-Hua Chen; Yi-Ling Ma; Tian-Huei Chu; Youn-Shen Bee; E-Ming Wang; Chang-Yi Wu; Ping-Jyun Sung; Zhi-Hong Wen; Deng-Chyang Wu; Jyh-Horng Sheu; Ming-Hong Tai
Journal:  Mar Drugs       Date:  2015-02-06       Impact factor: 5.118

9.  Antitumor Effects of Freeze-Dried Robusta Coffee (Coffea canephora) Extracts on Breast Cancer Cell Lines.

Authors:  Ayelén D Nigra; Deborah de Almeida Bauer Guimarães; César G Prucca; Otniel Freitas-Silva; Anderson J Teodoro; Germán A Gil
Journal:  Oxid Med Cell Longev       Date:  2021-05-18       Impact factor: 6.543

10.  A Novel Bispecific Antibody Targeting EGFR and VEGFR2 Is Effective against Triple Negative Breast Cancer via Multiple Mechanisms of Action.

Authors:  Nishant Mohan; Xiao Luo; Yi Shen; Zachary Olson; Atul Agrawal; Yukinori Endo; David S Rotstein; Lorraine C Pelosof; Wen Jin Wu
Journal:  Cancers (Basel)       Date:  2021-03-01       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.